ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

TRASTUZUMABUM EMTANSINUM

Active substance (INN) · ATC L01FD03 · 2 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
L01XC14	TRASTUZUMAB EMTANSINE	In force	medicine of the protocol	C2-P3	NO

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
KADCYLA 100mg	PULB. PT. CONC. PT. SOL. PERF.	100mg	ROCHE REGISTRATION GMBH - GERMANIA	L01FD03	PR
KADCYLA 160mg	PULB. PT. CONC. PT. SOL. PERF.	160mg	ROCHE REGISTRATION GMBH - GERMANIA	L01FD03	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.